Monte Rosa Therapeutics (GLUE) P/E (2021 - 2026)
Monte Rosa Therapeutics (GLUE) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM Monte Rosa Therapeutics (GLUE) P/E is -13.47. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Monte Rosa Therapeutics (GLUE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -13.47 | -60.14% |
| 2025 | -33.79 | +533.66% |
| 2024 | -5.33 | +152.89% |
| 2023 | -2.11 | -40.46% |
| 2022 | -3.54 | -76.71% |
| 2021 | -15.20 | N/A |
Comparison Monte Rosa Therapeutics (GLUE) P/E with competitors
Monte Rosa Therapeutics (GLUE) P/E is -13.47.